Proteomics in antitumor research

[1]  K. Shroyer,et al.  Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue , 2006, Molecular carcinogenesis.

[2]  R. Aebersold,et al.  Quantitative proteomic profiling of pancreatic cancer juice , 2006, Proteomics.

[3]  G. Christofori.  New signals from the invasive front , 2006, Nature.

[4]  K. Krapfenbauer,et al.  Identification of differentially expressed, tumor‐associated proteins in oral squamous cell carcinoma by proteomic analysis , 2006, Electrophoresis.

[5]  T. Pawlik,et al.  Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein , 2006, BMC Cancer.

[6]  Virginia Espina,et al.  Proteomic Analysis of Apoptotic Pathways Reveals Prognostic Factors in Follicular Lymphoma , 2005, Clinical Cancer Research.

[7]  L. Silengo,et al.  Systematic Analysis of the Epidermal Growth Factor Receptor by Mass Spectrometry Reveals Stimulation-dependent Multisite Phosphorylation*S , 2005, Molecular & Cellular Proteomics.

[8]  A. Scarpa,et al.  Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  Yoon Pin Lim,et al.  Mining the Tumor Phosphoproteome for Cancer Markers , 2005, Clinical Cancer Research.

[10]  Francesca Antonucci,et al.  Numerical approaches for quantitative analysis of two‐dimensional maps: A review of commercial software and home‐made systems , 2005, Proteomics.

[11]  J. Rush,et al.  Immunoaffinity profiling of tyrosine phosphorylation in cancer cells , 2005, Nature Biotechnology.

[12]  Alexander Leitner,et al.  Current chemical tagging strategies for proteome analysis by mass spectrometry. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[13]  M. Weiner,et al.  Molecular biomarkers in drug development. , 2004, Drug discovery today.

[14]  Troels Z. Kristiansen,et al.  Comprehensive proteomic analysis of human pancreatic juice. , 2004, Journal of proteome research.

[15]  Steven P Gygi,et al.  Large-scale characterization of HeLa cell nuclear phosphoproteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. Ornstein,et al.  Proteomics to diagnose human tumors and provide prognostic information. , 2004, Oncology.

[17]  T. Buschmann,et al.  Proteome Analysis for the Identification of Tumor-Associated Biomarkers in Gastrointestinal Cancer , 2004, Digestive Diseases.

[18]  William C Reinhold,et al.  Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[19]  William C Reinhold,et al.  Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling. , 2003, Cancer research.

[20]  B. Riederer,et al.  Sample preparation for two‐dimensional gel electrophoresis , 2003, Proteomics.

[21]  Emanuel F Petricoin,et al.  Protein microarrays: meeting analytical challenges for clinical applications. , 2003, Cancer cell.

[22]  R. Aebersold,et al.  Mass spectrometry-based proteomics , 2003, Nature.

[23]  R. Aebersold,et al.  Proteomics: the first decade and beyond , 2003, Nature Genetics.

[24]  M. Snyder,et al.  Protein chip technology. , 2003, Current opinion in chemical biology.

[25]  D. Chan,et al.  Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. , 2002, Clinical chemistry.

[26]  Mukesh Verma,et al.  Proteomics for Cancer Biomarker Discovery , 2002 .

[27]  T. Haystead,et al.  Molecular Biologist's Guide to Proteomics , 2002, Microbiology and Molecular Biology Reviews.

[28]  E. Petricoin,et al.  Use of proteomic patterns in serum to identify ovarian cancer , 2002, The Lancet.

[29]  S. Gygi,et al.  Proteomics: the move to mixtures. , 2001, Journal of mass spectrometry : JMS.

[30]  E. Petricoin,et al.  Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front , 2001, Oncogene.

[31]  D. DeMets,et al.  Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.

[32]  K. Resing,et al.  Identification of novel MAP kinase pathway signaling targets by functional proteomics and mass spectrometry. , 2000, Molecular cell.

[33]  M. Merchant,et al.  A rapid protein profiling system that speeds study of cancer and other diseases. , 2000, American clinical laboratory.

[34]  S. Gygi,et al.  Quantitative analysis of complex protein mixtures using isotope-coded affinity tags , 1999, Nature Biotechnology.

[35]  S. Gygi,et al.  Protein analysis by mass spectrometry and sequence database searching: Tools for cancer research in the post‐genomic era , 1999, Electrophoresis.

[36]  T. Blumenthal,et al.  Electron‐impact studies—LXXIV: A survey of rearrangement processes in the ‘doubly‐charged ion’ mass spectra of aromatic compounds , 1972 .

[37]  A. Schmidt,et al.  A novel strategy for quantitative proteomics using isotope‐coded protein labels , 2005, Proteomics.

[38]  Kelly K. Hunt,et al.  Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry , 2004, Breast Cancer Research and Treatment.

[39]  M. Mann,et al.  Analysis of proteins and proteomes by mass spectrometry. , 2001, Annual review of biochemistry.

[40]  J. Yates.  Mass spectrometry and the age of the proteome. , 1998, Journal of mass spectrometry : JMS.